Corporate News 09-Feb-24
Biocon receives Complete Response Letter for Biologics License Application
From USFDA
Biocon announced that the U.S. Food and Drug Administration (US FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for bBevacizumab. The CRL did not identify any outstanding scientific issues on the dossier and informs the need for the completion of a pre-approval inspection of the bBevacizumab manufacturing facility.
Previous News
Biocon Ltd up for fifth session
( Hot Pursuit - 22-Aug-24 13:00 )
Biocon slips after CFO resigns
( Hot Pursuit - 15-Mar-24 11:08 )
Biocon Biologics partners with Sandoz AG
( Corporate News - 09-Feb-24 09:15 )
Biocon receives Complete Response Letter for Biologics License Application
( Corporate News - 09-Feb-24 09:11 )
Biocon Ltd soars 1.22%, rises for fifth straight session
( Hot Pursuit - 27-Mar-24 13:00 )
Biocon Biologics refinances debt through USD bonds and syndicated term loan
( Corporate News - 03-Oct-24 09:29 )
Biocon arm inks pact to launch biosimilar Bmab 1200 in multiple countries
( Hot Pursuit - 29-Aug-24 12:21 )
Biocon consolidated net profit rises 167.80% in the September 2023 quarter
( Results - Announcements 10-Nov-23 17:28 )
Biocon records turnaround PAT of Rs 660 cr in Q3
( Hot Pursuit - 09-Feb-24 14:12 )
Biocon Biologics strengthens its leadership team
( Corporate News - 04-Aug-23 16:05 )
Volumes jump at Akzo Nobel India Ltd counter
( Hot Pursuit - 10-Feb-23 11:00 )
Other Stories
RACL Geartech receives ratings action from CARE
05-Oct-24 14:24
JHS Svendgaard Retail Ventures EGM scheduled
05-Oct-24 13:50
Lexus Granito (India) EGM scheduled
05-Oct-24 13:50
Latteys Industries EGM scheduled
05-Oct-24 13:50
Embassy Office Parks REIT to convene board meeting
05-Oct-24 13:50
Board of Fusion Micro Finance appoints director
05-Oct-24 13:17
Board of Fusion Micro Finance approves rights issue of Rs 550 cr
05-Oct-24 13:15
Bharti Airtel deploys additional spectrum in Jammu-Kashmir & Leh Ladakh
05-Oct-24 12:53
Dr Reddys announces incorporation of new step-down subsidiary in Denmark
05-Oct-24 11:37
360 ONE WAM grants 21.47 lakh stock options
05-Oct-24 11:32
Back
Top
